Delivery Order SPE2DB20D2014-SPE2DB25FA96L

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,111.94 firm fixed price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medical products. The contract has an ultimate completion date of August 29, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $1,017.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a performance period through February 18, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, with a ceiling value of $12,650.97 and a performance period ending on July 23, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,704.04 firm fixed-price delivery order is for the supply of AIMOVIG 140 MG/ML autoinjectors, with a period of performance through January 3, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,256.01, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a prescription medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of November 7, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,496.94 delivery order contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of February 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,691.60 delivery order is for AIMOVIG 140 MG/ML AUTOINJECTORML, and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,632.04 firm-fixed price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,026.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, with a completion date of December 23, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA96L
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,209.32 delivery order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order award is for a period running through February 2025 and is priced on a firm fixed-price basis.

Generated 5/5/25, 9:42 AM